“I think we are in a revolution that no one believed would happen.”
An Oxford University lab study yet to be peer-reviewed found that three AstraZeneca vaccines provide protection against the COVID Omicron variant.
The congresswoman owns stock in Pfizer, AstraZeneca and Johnson&Johnson despite claiming to be unvaccinated and being among the most vocal opponents of vaccine mandates.
The novel coronavirus has killed 5.26 million people across the world, wiped out trillions of dollars in economic output and turned life upside down for billions of people.
The data give hope of additional protection for people who do not respond well to vaccines, such as cancer patients.
The Anglo-Swedish company also said that patients with mild-to-moderate COVID-19 showed a higher dose of the drug cut the risk of symptoms worsening by 88% when given within three days.
A study showed that Valneva's vaccine, given in two shots 28 days apart, prompted significantly fewer adverse reactions, such as arm pain and fever.
The country is on the cusp of 8,000 deaths since the beginning of the pandemic.
The medicine has proven to work in the non-infected and was also shown to save lives and prevent severe disease when given as treatment within a week of first symptoms.
According to the study, which included the data of more than one million people, the Chinese-developed Sinopharm vaccine was less suitable for those over 50 years old.